SlideShare ist ein Scribd-Unternehmen logo
1 von 34
Downloaden Sie, um offline zu lesen
Epidemiology of CHD risk factors in Saudi Arabia Dr. Alaa Elalem Medical Department Pfizer, Jeddah, Saudi Arabia
 
 
 
 
Young population 79 % under age of 40 42 % under age of 20 16 %at age of  40-60 5  % over age of  60 WHR2006
Life expectancy at birth WHR 2006 Rank Country Life expectancy at birth  ( years) 1 San Marino 82 3 Japan 82 20 Germany 79 28 USA 78 38 UAE 77 61 Syria 72 80 Saudi Arabia 71 88 Turkey 71 107 Egypt 68 192 Zimbabwe 36
Global distribution of healthcare Physicians WHR 2006 Rank Country Physician Density per 1000 1 San Marino 47.35 / 1990 26 Germany 3.37 / 2003 47 USA 2.56 / 2000 62 UAE 2.02 / 2001 64 Japan 1.98 / 2002 76 Syria 1.40 / 2001 77 Saudi Arabia 1.30 / 2004 79 Turkey 1.35 / 2003 120 Egypt 0.54 / 2003 192 Malawi 0.02 / 2004
Global distribution of healthcare Pharmacists WHR 2006 Rank Country Pharmacist Density per 1000 1 Jordan 3.14 / 2004 5 Japan 2.21 / 2002 19 USA 0.88 / 2000 37 Germany 0.58 / 2003 45 Syria 0.52 / 2001 59 UAE 0.38 / 2001 63 Turkey 0.32 / 2003 76 Saudi Arabia 0.22 / 2004 94 Egypt 0.10 / 2004 161 Somalia (8) 0.00 / 1997 162 Cuba 0
Global distribution of healthcare Nurses WHR 2006 Rank Country Nurses density per 1000 1 San Marino 95.48 / 1990 15 Germany 9.72 / 2003 19 U.S.A. 9.37 / 2000 27 Japan 7.79 / 2002 60 U.A.E. 4.18 / 2001 88 Saudi Arabia 2.97 / 2004 104 Egypt 2.00 / 2004 106 Syria 1.94 / 2001 111 Turkey 1.70 / 2003 190 Bangladesh 0.14 / 2004
Healthcare expenditure indicators WHR 2006 Rank Country Per Capital Total Expenditure on Health at international dollar Rate (US$)- 2003 1 USA 5711 8 Germany 3001 21 Japan 2244 54 UAE 623 59 Saudi Arabia 578 67 Turkey 528 108 Egypt 235 137 Syria 116 191 Democratic republic of Congo 14
Healthcare expenditure indicators WHR 2006 Rank Country Total Expenditure of Health as % of GDP -2003 1 USA 15.2 6 Germany 11.1 10 Lebanon 10.2 41 Japan 7.9 48 Turkey 7.6 97 Egypt 5.8 122 Syria 5.1 154 Saudi Arabia 4 175 UAE 3.3 191 Equatorial  Guinea 1.5
Health care expenditure  WHR 2006
Health care expenditure  WHR 2006
Top 10   cause of Death in K.S.A.
Top 10   cause of Death in K.S.A. 30 %
[object Object],[object Object],1-Al Balla SR,. J Trop Med Hyg 1993;96:157-62  2-Bamgboye EA, Saudi Med J 1993;13(1):8-13. ] .
C.H.D. Risk Factors ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],2- Non  Modifiable: 1- Modifiable : Age  Male gender Family History
Prevalence of Hypertension in Saudi Arabia AL-Nozha et al in a cross-sectional cluster sampling & house hold  survey on 13700 Saudis of both sexes Kingdomwide Ann Saudi Med, Vol 17, No2.1997
Comparative Prevalence of hypertension and the expected hypertension population in each country Journal of Hypertension 2005, Vol 23 No 6
Cost of Hypertension in S.A ,[object Object],[object Object]
Prevalence of dyslipidemia in Saudi Adults ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Al-Nozha MM.et al. Metabolic syndrome in Saudi Arabia. Saudi Med J 2005; 26 (12): 1918-1925
Prevalence of DM in Saudi Arabia
Prevalence of DM in Saudi Arabia
Prevalence of DM in Saudi Adults Overall prevalence rate of Diabetes Mellitus was is  23.7%  and IFG  14.1%  based on 1997 American Diabetes Association (ADA) criteria and adopted by the World Health Organization (WHO) in 1998  Al-Nozha MM et al. Diabetes mellitus in Saudi Arabia. Saudi Med J 2004;25 (11): 1603-1610
 
 
General Mortality in Saudi diabetics 2000 Saudi diabetics ( Initial )
Prevalence of obesity in Saudi Adults
Prevalence of obesity in Saudi Adults
Prevalence of obesity in Saudi Adults
Prevalence of Metabolic Syndrome in Saudi Adults Overall prevalence rate of metabolic syndrome as defined by the Adult Treatment Panel (ATP) III in 2001 was  39.3%.
The prevalence of regular smokers in each country Journal of Hypertension 2005, Vol 23 No 6
“A Man is as Old as His Arteries” Dr Thomas Sydenham (1624-89 )

Weitere ähnliche Inhalte

Was ist angesagt?

Role of statin and clopidogrel in atherothrombotic events
Role of statin and clopidogrel in atherothrombotic eventsRole of statin and clopidogrel in atherothrombotic events
Role of statin and clopidogrel in atherothrombotic eventsPraveen Nagula
 
DELIVER delivered 2022.pptx
DELIVER delivered 2022.pptxDELIVER delivered 2022.pptx
DELIVER delivered 2022.pptxhospital
 
Management of Hypertension and Diabetes in Aging People 2014
Management of Hypertension and Diabetes in Aging People 2014Management of Hypertension and Diabetes in Aging People 2014
Management of Hypertension and Diabetes in Aging People 2014Nemencio Jr
 
Diabetic dyslipidemia and Saroglitazar
Diabetic dyslipidemia and SaroglitazarDiabetic dyslipidemia and Saroglitazar
Diabetic dyslipidemia and SaroglitazarDr Vivek Baliga
 
Diabetes mellitus and hypertension
Diabetes mellitus and hypertensionDiabetes mellitus and hypertension
Diabetes mellitus and hypertensionNadia Shams
 
Heart Failure Care: How World-Class Performance is Within Your Reach
Heart Failure Care: How World-Class Performance is Within Your ReachHeart Failure Care: How World-Class Performance is Within Your Reach
Heart Failure Care: How World-Class Performance is Within Your ReachHealth Catalyst
 
Fixed Dose combination ppt
Fixed Dose combination  pptFixed Dose combination  ppt
Fixed Dose combination pptKamini Sharma
 
Hope 3 (stat + antihypertensives) TRIAL
Hope 3 (stat + antihypertensives) TRIALHope 3 (stat + antihypertensives) TRIAL
Hope 3 (stat + antihypertensives) TRIALIqbal Dar
 
Telsarta-A final-01-04-16
Telsarta-A  final-01-04-16Telsarta-A  final-01-04-16
Telsarta-A final-01-04-16Muhammad Aun
 
SGLT2 inhibitors in Heart failure: A prized addition to HF treatment options
SGLT2 inhibitors in Heart failure: A prized addition to HF treatment optionsSGLT2 inhibitors in Heart failure: A prized addition to HF treatment options
SGLT2 inhibitors in Heart failure: A prized addition to HF treatment optionsahvc0858
 
Stroke Prevention in Atrial Fibrillation
Stroke Prevention in Atrial FibrillationStroke Prevention in Atrial Fibrillation
Stroke Prevention in Atrial FibrillationGillian Gordon Perue
 
Cardiovascular safety of anti-diabetic drugs.Cardiovascular Outcome Trials ...
Cardiovascular safety of anti-diabetic drugs.Cardiovascular Outcome Trials  ...Cardiovascular safety of anti-diabetic drugs.Cardiovascular Outcome Trials  ...
Cardiovascular safety of anti-diabetic drugs.Cardiovascular Outcome Trials ...magdy elmasry
 
Residual CV risk: what is this? Role of lipids and inflammation and how to id...
Residual CV risk: what is this? Role of lipids and inflammation and how to id...Residual CV risk: what is this? Role of lipids and inflammation and how to id...
Residual CV risk: what is this? Role of lipids and inflammation and how to id...Sociedad Española de Cardiología
 
Management strategy in HF with ARNI - Recent updates
Management strategy in HF with ARNI - Recent updates Management strategy in HF with ARNI - Recent updates
Management strategy in HF with ARNI - Recent updates Praveen Nagula
 

Was ist angesagt? (20)

Role of statin and clopidogrel in atherothrombotic events
Role of statin and clopidogrel in atherothrombotic eventsRole of statin and clopidogrel in atherothrombotic events
Role of statin and clopidogrel in atherothrombotic events
 
DELIVER delivered 2022.pptx
DELIVER delivered 2022.pptxDELIVER delivered 2022.pptx
DELIVER delivered 2022.pptx
 
Management of Hypertension and Diabetes in Aging People 2014
Management of Hypertension and Diabetes in Aging People 2014Management of Hypertension and Diabetes in Aging People 2014
Management of Hypertension and Diabetes in Aging People 2014
 
Diabetic dyslipidemia and Saroglitazar
Diabetic dyslipidemia and SaroglitazarDiabetic dyslipidemia and Saroglitazar
Diabetic dyslipidemia and Saroglitazar
 
Ramadan and cvd
Ramadan and cvdRamadan and cvd
Ramadan and cvd
 
Diabetes mellitus and hypertension
Diabetes mellitus and hypertensionDiabetes mellitus and hypertension
Diabetes mellitus and hypertension
 
Heart Failure Care: How World-Class Performance is Within Your Reach
Heart Failure Care: How World-Class Performance is Within Your ReachHeart Failure Care: How World-Class Performance is Within Your Reach
Heart Failure Care: How World-Class Performance is Within Your Reach
 
Fixed Dose combination ppt
Fixed Dose combination  pptFixed Dose combination  ppt
Fixed Dose combination ppt
 
Hope 3 (stat + antihypertensives) TRIAL
Hope 3 (stat + antihypertensives) TRIALHope 3 (stat + antihypertensives) TRIAL
Hope 3 (stat + antihypertensives) TRIAL
 
Telsarta-A final-01-04-16
Telsarta-A  final-01-04-16Telsarta-A  final-01-04-16
Telsarta-A final-01-04-16
 
CONTROVERSIES FOR ASIAN PATIENTS
CONTROVERSIES FOR ASIAN PATIENTSCONTROVERSIES FOR ASIAN PATIENTS
CONTROVERSIES FOR ASIAN PATIENTS
 
TELMISARTAN.pptx
TELMISARTAN.pptxTELMISARTAN.pptx
TELMISARTAN.pptx
 
SGLT2 inhibitors in Heart failure: A prized addition to HF treatment options
SGLT2 inhibitors in Heart failure: A prized addition to HF treatment optionsSGLT2 inhibitors in Heart failure: A prized addition to HF treatment options
SGLT2 inhibitors in Heart failure: A prized addition to HF treatment options
 
Stroke Prevention in Atrial Fibrillation
Stroke Prevention in Atrial FibrillationStroke Prevention in Atrial Fibrillation
Stroke Prevention in Atrial Fibrillation
 
Review on trials of clopidogrel
Review on trials of clopidogrelReview on trials of clopidogrel
Review on trials of clopidogrel
 
Cardiovascular safety of anti-diabetic drugs.Cardiovascular Outcome Trials ...
Cardiovascular safety of anti-diabetic drugs.Cardiovascular Outcome Trials  ...Cardiovascular safety of anti-diabetic drugs.Cardiovascular Outcome Trials  ...
Cardiovascular safety of anti-diabetic drugs.Cardiovascular Outcome Trials ...
 
Residual CV risk: what is this? Role of lipids and inflammation and how to id...
Residual CV risk: what is this? Role of lipids and inflammation and how to id...Residual CV risk: what is this? Role of lipids and inflammation and how to id...
Residual CV risk: what is this? Role of lipids and inflammation and how to id...
 
Management strategy in HF with ARNI - Recent updates
Management strategy in HF with ARNI - Recent updates Management strategy in HF with ARNI - Recent updates
Management strategy in HF with ARNI - Recent updates
 
Clinical Case Study PPT
Clinical Case Study PPTClinical Case Study PPT
Clinical Case Study PPT
 
De-escalation of P2Y12 Inhibitors - Dr. Aradi
De-escalation of P2Y12 Inhibitors - Dr. AradiDe-escalation of P2Y12 Inhibitors - Dr. Aradi
De-escalation of P2Y12 Inhibitors - Dr. Aradi
 

Andere mochten auch (15)

Obesity
ObesityObesity
Obesity
 
ueda2012 advance trial-d.salah
ueda2012 advance trial-d.salahueda2012 advance trial-d.salah
ueda2012 advance trial-d.salah
 
Veno occlusive disease
Veno occlusive diseaseVeno occlusive disease
Veno occlusive disease
 
Obesity in The UAE
Obesity in The UAEObesity in The UAE
Obesity in The UAE
 
smoking
smokingsmoking
smoking
 
Sprint trial
Sprint trialSprint trial
Sprint trial
 
SPRINT trial
SPRINT trialSPRINT trial
SPRINT trial
 
Hypertension - Approach & Management
Hypertension - Approach & ManagementHypertension - Approach & Management
Hypertension - Approach & Management
 
National NCD Program in Oman
National NCD Program in OmanNational NCD Program in Oman
National NCD Program in Oman
 
Chronic diseases and their risk factors in the Kingdom of Saudi Arabia
Chronic diseases and their risk factors in the Kingdom of Saudi ArabiaChronic diseases and their risk factors in the Kingdom of Saudi Arabia
Chronic diseases and their risk factors in the Kingdom of Saudi Arabia
 
What Is Population Health And How Does It Compare to Public Health
What Is Population Health And How Does It Compare to Public HealthWhat Is Population Health And How Does It Compare to Public Health
What Is Population Health And How Does It Compare to Public Health
 
Pulmonary hypertension
Pulmonary hypertensionPulmonary hypertension
Pulmonary hypertension
 
Smoking & periodontium
Smoking & periodontiumSmoking & periodontium
Smoking & periodontium
 
Obesity
ObesityObesity
Obesity
 
Obesity Presentation
Obesity PresentationObesity Presentation
Obesity Presentation
 

Ähnlich wie Health Stats Ksa

Ueda2016 metabolic syndrome in different population,which one is appropriate ...
Ueda2016 metabolic syndrome in different population,which one is appropriate ...Ueda2016 metabolic syndrome in different population,which one is appropriate ...
Ueda2016 metabolic syndrome in different population,which one is appropriate ...ueda2015
 
Part 1, MHFS,why to build MDHFP
Part 1, MHFS,why to build MDHFPPart 1, MHFS,why to build MDHFP
Part 1, MHFS,why to build MDHFPasadsoomro1960
 
Ndei Cardiovascular Disease In Diabetes Epidemiology
Ndei Cardiovascular Disease In Diabetes EpidemiologyNdei Cardiovascular Disease In Diabetes Epidemiology
Ndei Cardiovascular Disease In Diabetes Epidemiologydavid7s
 
Makkah HF registry oct 2021
Makkah HF registry oct 2021Makkah HF registry oct 2021
Makkah HF registry oct 2021asadsoomro1960
 
Metabolic syndrome in Community Medicine
Metabolic syndrome in Community Medicine Metabolic syndrome in Community Medicine
Metabolic syndrome in Community Medicine Dr. Anees Alyafei
 
The diabetic foot disorder in arabs countries a neglected clinical problem
The diabetic foot disorder in arabs countries a neglected clinical problemThe diabetic foot disorder in arabs countries a neglected clinical problem
The diabetic foot disorder in arabs countries a neglected clinical problemuvcd
 
Epidemiología de la Resistencia a la Insulina, Diabetes Mellitus y Enfermedad...
Epidemiología de la Resistencia a la Insulina, Diabetes Mellitus y Enfermedad...Epidemiología de la Resistencia a la Insulina, Diabetes Mellitus y Enfermedad...
Epidemiología de la Resistencia a la Insulina, Diabetes Mellitus y Enfermedad...Dr. Jair García-Guerrero
 
Ueda 2016 diabetes atlas - nam cho
Ueda 2016 diabetes atlas  - nam choUeda 2016 diabetes atlas  - nam cho
Ueda 2016 diabetes atlas - nam choueda2015
 
د فيصل الناصر
د فيصل الناصرد فيصل الناصر
د فيصل الناصرAlbert Seo
 
presentation de Chandralall Sookram
presentation de Chandralall Sookrampresentation de Chandralall Sookram
presentation de Chandralall Sookramtsoret1
 
Coronary heart disease - epidemiology
Coronary heart disease - epidemiologyCoronary heart disease - epidemiology
Coronary heart disease - epidemiologyGarima Gupta
 
Abbotsford feb 26 2014
Abbotsford feb 26 2014Abbotsford feb 26 2014
Abbotsford feb 26 2014Ihsaan Peer
 
Regional epidemiology of hypertension in the Gulf
Regional epidemiology of hypertension in the GulfRegional epidemiology of hypertension in the Gulf
Regional epidemiology of hypertension in the GulfJAFAR ALSAID
 
Atherogenic effects ofDiabetic Dyslipidemia.ppsx
Atherogenic effects ofDiabetic Dyslipidemia.ppsxAtherogenic effects ofDiabetic Dyslipidemia.ppsx
Atherogenic effects ofDiabetic Dyslipidemia.ppsxSrikrishna177594
 
ueda2012 do we still need high doses-d.mohammed
ueda2012 do we still need high doses-d.mohammedueda2012 do we still need high doses-d.mohammed
ueda2012 do we still need high doses-d.mohammedueda2015
 
ueda2011 diabetes in arb-d.nabil
ueda2011 diabetes in arb-d.nabilueda2011 diabetes in arb-d.nabil
ueda2011 diabetes in arb-d.nabilueda2015
 

Ähnlich wie Health Stats Ksa (20)

Ueda2016 metabolic syndrome in different population,which one is appropriate ...
Ueda2016 metabolic syndrome in different population,which one is appropriate ...Ueda2016 metabolic syndrome in different population,which one is appropriate ...
Ueda2016 metabolic syndrome in different population,which one is appropriate ...
 
Part 1, MHFS,why to build MDHFP
Part 1, MHFS,why to build MDHFPPart 1, MHFS,why to build MDHFP
Part 1, MHFS,why to build MDHFP
 
Ndei Cardiovascular Disease In Diabetes Epidemiology
Ndei Cardiovascular Disease In Diabetes EpidemiologyNdei Cardiovascular Disease In Diabetes Epidemiology
Ndei Cardiovascular Disease In Diabetes Epidemiology
 
Makkah HF registry oct 2021
Makkah HF registry oct 2021Makkah HF registry oct 2021
Makkah HF registry oct 2021
 
Type 2 DM ; Metformin Best Partner
Type 2 DM ; Metformin Best PartnerType 2 DM ; Metformin Best Partner
Type 2 DM ; Metformin Best Partner
 
Diabetes
DiabetesDiabetes
Diabetes
 
Metabolic syndrome in Community Medicine
Metabolic syndrome in Community Medicine Metabolic syndrome in Community Medicine
Metabolic syndrome in Community Medicine
 
Ghada Nasr (Cairo University)• 2020 IFPRI Egypt - FAO Seminar: "Food Policies...
Ghada Nasr (Cairo University)• 2020 IFPRI Egypt - FAO Seminar: "Food Policies...Ghada Nasr (Cairo University)• 2020 IFPRI Egypt - FAO Seminar: "Food Policies...
Ghada Nasr (Cairo University)• 2020 IFPRI Egypt - FAO Seminar: "Food Policies...
 
The diabetic foot disorder in arabs countries a neglected clinical problem
The diabetic foot disorder in arabs countries a neglected clinical problemThe diabetic foot disorder in arabs countries a neglected clinical problem
The diabetic foot disorder in arabs countries a neglected clinical problem
 
Epidemiología de la Resistencia a la Insulina, Diabetes Mellitus y Enfermedad...
Epidemiología de la Resistencia a la Insulina, Diabetes Mellitus y Enfermedad...Epidemiología de la Resistencia a la Insulina, Diabetes Mellitus y Enfermedad...
Epidemiología de la Resistencia a la Insulina, Diabetes Mellitus y Enfermedad...
 
Ueda 2016 diabetes atlas - nam cho
Ueda 2016 diabetes atlas  - nam choUeda 2016 diabetes atlas  - nam cho
Ueda 2016 diabetes atlas - nam cho
 
د فيصل الناصر
د فيصل الناصرد فيصل الناصر
د فيصل الناصر
 
Ghada Nasr (Cairo University) • 2019 IFPRI Egypt - NNC Seminar: "100 million ...
Ghada Nasr (Cairo University) • 2019 IFPRI Egypt - NNC Seminar: "100 million ...Ghada Nasr (Cairo University) • 2019 IFPRI Egypt - NNC Seminar: "100 million ...
Ghada Nasr (Cairo University) • 2019 IFPRI Egypt - NNC Seminar: "100 million ...
 
presentation de Chandralall Sookram
presentation de Chandralall Sookrampresentation de Chandralall Sookram
presentation de Chandralall Sookram
 
Coronary heart disease - epidemiology
Coronary heart disease - epidemiologyCoronary heart disease - epidemiology
Coronary heart disease - epidemiology
 
Abbotsford feb 26 2014
Abbotsford feb 26 2014Abbotsford feb 26 2014
Abbotsford feb 26 2014
 
Regional epidemiology of hypertension in the Gulf
Regional epidemiology of hypertension in the GulfRegional epidemiology of hypertension in the Gulf
Regional epidemiology of hypertension in the Gulf
 
Atherogenic effects ofDiabetic Dyslipidemia.ppsx
Atherogenic effects ofDiabetic Dyslipidemia.ppsxAtherogenic effects ofDiabetic Dyslipidemia.ppsx
Atherogenic effects ofDiabetic Dyslipidemia.ppsx
 
ueda2012 do we still need high doses-d.mohammed
ueda2012 do we still need high doses-d.mohammedueda2012 do we still need high doses-d.mohammed
ueda2012 do we still need high doses-d.mohammed
 
ueda2011 diabetes in arb-d.nabil
ueda2011 diabetes in arb-d.nabilueda2011 diabetes in arb-d.nabil
ueda2011 diabetes in arb-d.nabil
 

Mehr von hospital

Nuclear cases Saturday 2023.pptx
Nuclear cases Saturday 2023.pptxNuclear cases Saturday 2023.pptx
Nuclear cases Saturday 2023.pptxhospital
 
2023 HF p EF.pptx
2023 HF p EF.pptx2023 HF p EF.pptx
2023 HF p EF.pptxhospital
 
SURGICAL MANGEMNT of VHD 2023fffffffff.pptx
SURGICAL MANGEMNT of VHD 2023fffffffff.pptxSURGICAL MANGEMNT of VHD 2023fffffffff.pptx
SURGICAL MANGEMNT of VHD 2023fffffffff.pptxhospital
 
Reading and interpreting Holter2023.pptx
Reading and interpreting Holter2023.pptxReading and interpreting Holter2023.pptx
Reading and interpreting Holter2023.pptxhospital
 
Complications_of_Diabetes.ppt
Complications_of_Diabetes.pptComplications_of_Diabetes.ppt
Complications_of_Diabetes.ppthospital
 
SURGICAL MANGEMNT of VHD 2023.pptx
SURGICAL MANGEMNT of VHD 2023.pptxSURGICAL MANGEMNT of VHD 2023.pptx
SURGICAL MANGEMNT of VHD 2023.pptxhospital
 
the worst Medical Errors and how to mange them.pptx
the worst  Medical Errors and how to mange them.pptxthe worst  Medical Errors and how to mange them.pptx
the worst Medical Errors and how to mange them.pptxhospital
 
Radionuclide Imaging of Cardiac Amyloidosis and SarcoidosisFELLOWS LECTUREupd...
Radionuclide Imaging of Cardiac Amyloidosis and SarcoidosisFELLOWS LECTUREupd...Radionuclide Imaging of Cardiac Amyloidosis and SarcoidosisFELLOWS LECTUREupd...
Radionuclide Imaging of Cardiac Amyloidosis and SarcoidosisFELLOWS LECTUREupd...hospital
 
End Organ Damage In HypertensionDARB.pptx
End Organ Damage In HypertensionDARB.pptxEnd Organ Damage In HypertensionDARB.pptx
End Organ Damage In HypertensionDARB.pptxhospital
 
Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction REV...
Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction  REV...Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction  REV...
Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction REV...hospital
 
Acetazolamide in Acute Decompensated Heart Failure with Volume ADVOR.pptx
Acetazolamide in Acute Decompensated Heart Failure with Volume ADVOR.pptxAcetazolamide in Acute Decompensated Heart Failure with Volume ADVOR.pptx
Acetazolamide in Acute Decompensated Heart Failure with Volume ADVOR.pptxhospital
 
MRCP SUDAN QUESTIONS.pptx
MRCP SUDAN QUESTIONS.pptxMRCP SUDAN QUESTIONS.pptx
MRCP SUDAN QUESTIONS.pptxhospital
 
DM LECTURE PROJECT.pptx
DM LECTURE  PROJECT.pptxDM LECTURE  PROJECT.pptx
DM LECTURE PROJECT.pptxhospital
 
Learning case of strongly positive PET-CT Rubidium 82 on all parameters.ppt
Learning case of strongly positive PET-CT Rubidium 82 on all parameters.pptLearning case of strongly positive PET-CT Rubidium 82 on all parameters.ppt
Learning case of strongly positive PET-CT Rubidium 82 on all parameters.ppthospital
 
The Role of PET-CT imaging in the diagnosis of cardiac sarcoidosis post cardi...
The Role of PET-CT imaging in the diagnosis of cardiac sarcoidosis post cardi...The Role of PET-CT imaging in the diagnosis of cardiac sarcoidosis post cardi...
The Role of PET-CT imaging in the diagnosis of cardiac sarcoidosis post cardi...hospital
 
Diabetes mellitus and vascular disease 2022 FINALD.pptx
Diabetes mellitus and vascular disease 2022 FINALD.pptxDiabetes mellitus and vascular disease 2022 FINALD.pptx
Diabetes mellitus and vascular disease 2022 FINALD.pptxhospital
 
Nuc part BBBB.pptx
Nuc part BBBB.pptxNuc part BBBB.pptx
Nuc part BBBB.pptxhospital
 
Non Invasive testing of myocardial ischemia AA.pptx
Non Invasive testing of myocardial ischemia AA.pptxNon Invasive testing of myocardial ischemia AA.pptx
Non Invasive testing of myocardial ischemia AA.pptxhospital
 
Inherited aortopathy2022
Inherited aortopathy2022Inherited aortopathy2022
Inherited aortopathy2022hospital
 
The role of cardiac devise therapy in heart2021 ihab
The role of cardiac devise therapy in heart2021 ihabThe role of cardiac devise therapy in heart2021 ihab
The role of cardiac devise therapy in heart2021 ihabhospital
 

Mehr von hospital (20)

Nuclear cases Saturday 2023.pptx
Nuclear cases Saturday 2023.pptxNuclear cases Saturday 2023.pptx
Nuclear cases Saturday 2023.pptx
 
2023 HF p EF.pptx
2023 HF p EF.pptx2023 HF p EF.pptx
2023 HF p EF.pptx
 
SURGICAL MANGEMNT of VHD 2023fffffffff.pptx
SURGICAL MANGEMNT of VHD 2023fffffffff.pptxSURGICAL MANGEMNT of VHD 2023fffffffff.pptx
SURGICAL MANGEMNT of VHD 2023fffffffff.pptx
 
Reading and interpreting Holter2023.pptx
Reading and interpreting Holter2023.pptxReading and interpreting Holter2023.pptx
Reading and interpreting Holter2023.pptx
 
Complications_of_Diabetes.ppt
Complications_of_Diabetes.pptComplications_of_Diabetes.ppt
Complications_of_Diabetes.ppt
 
SURGICAL MANGEMNT of VHD 2023.pptx
SURGICAL MANGEMNT of VHD 2023.pptxSURGICAL MANGEMNT of VHD 2023.pptx
SURGICAL MANGEMNT of VHD 2023.pptx
 
the worst Medical Errors and how to mange them.pptx
the worst  Medical Errors and how to mange them.pptxthe worst  Medical Errors and how to mange them.pptx
the worst Medical Errors and how to mange them.pptx
 
Radionuclide Imaging of Cardiac Amyloidosis and SarcoidosisFELLOWS LECTUREupd...
Radionuclide Imaging of Cardiac Amyloidosis and SarcoidosisFELLOWS LECTUREupd...Radionuclide Imaging of Cardiac Amyloidosis and SarcoidosisFELLOWS LECTUREupd...
Radionuclide Imaging of Cardiac Amyloidosis and SarcoidosisFELLOWS LECTUREupd...
 
End Organ Damage In HypertensionDARB.pptx
End Organ Damage In HypertensionDARB.pptxEnd Organ Damage In HypertensionDARB.pptx
End Organ Damage In HypertensionDARB.pptx
 
Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction REV...
Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction  REV...Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction  REV...
Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction REV...
 
Acetazolamide in Acute Decompensated Heart Failure with Volume ADVOR.pptx
Acetazolamide in Acute Decompensated Heart Failure with Volume ADVOR.pptxAcetazolamide in Acute Decompensated Heart Failure with Volume ADVOR.pptx
Acetazolamide in Acute Decompensated Heart Failure with Volume ADVOR.pptx
 
MRCP SUDAN QUESTIONS.pptx
MRCP SUDAN QUESTIONS.pptxMRCP SUDAN QUESTIONS.pptx
MRCP SUDAN QUESTIONS.pptx
 
DM LECTURE PROJECT.pptx
DM LECTURE  PROJECT.pptxDM LECTURE  PROJECT.pptx
DM LECTURE PROJECT.pptx
 
Learning case of strongly positive PET-CT Rubidium 82 on all parameters.ppt
Learning case of strongly positive PET-CT Rubidium 82 on all parameters.pptLearning case of strongly positive PET-CT Rubidium 82 on all parameters.ppt
Learning case of strongly positive PET-CT Rubidium 82 on all parameters.ppt
 
The Role of PET-CT imaging in the diagnosis of cardiac sarcoidosis post cardi...
The Role of PET-CT imaging in the diagnosis of cardiac sarcoidosis post cardi...The Role of PET-CT imaging in the diagnosis of cardiac sarcoidosis post cardi...
The Role of PET-CT imaging in the diagnosis of cardiac sarcoidosis post cardi...
 
Diabetes mellitus and vascular disease 2022 FINALD.pptx
Diabetes mellitus and vascular disease 2022 FINALD.pptxDiabetes mellitus and vascular disease 2022 FINALD.pptx
Diabetes mellitus and vascular disease 2022 FINALD.pptx
 
Nuc part BBBB.pptx
Nuc part BBBB.pptxNuc part BBBB.pptx
Nuc part BBBB.pptx
 
Non Invasive testing of myocardial ischemia AA.pptx
Non Invasive testing of myocardial ischemia AA.pptxNon Invasive testing of myocardial ischemia AA.pptx
Non Invasive testing of myocardial ischemia AA.pptx
 
Inherited aortopathy2022
Inherited aortopathy2022Inherited aortopathy2022
Inherited aortopathy2022
 
The role of cardiac devise therapy in heart2021 ihab
The role of cardiac devise therapy in heart2021 ihabThe role of cardiac devise therapy in heart2021 ihab
The role of cardiac devise therapy in heart2021 ihab
 

Kürzlich hochgeladen

Team Lead Succeed – Helping you and your team achieve high-performance teamwo...
Team Lead Succeed – Helping you and your team achieve high-performance teamwo...Team Lead Succeed – Helping you and your team achieve high-performance teamwo...
Team Lead Succeed – Helping you and your team achieve high-performance teamwo...Association for Project Management
 
4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptx4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptxmary850239
 
Blowin' in the Wind of Caste_ Bob Dylan's Song as a Catalyst for Social Justi...
Blowin' in the Wind of Caste_ Bob Dylan's Song as a Catalyst for Social Justi...Blowin' in the Wind of Caste_ Bob Dylan's Song as a Catalyst for Social Justi...
Blowin' in the Wind of Caste_ Bob Dylan's Song as a Catalyst for Social Justi...DhatriParmar
 
Q-Factor General Quiz-7th April 2024, Quiz Club NITW
Q-Factor General Quiz-7th April 2024, Quiz Club NITWQ-Factor General Quiz-7th April 2024, Quiz Club NITW
Q-Factor General Quiz-7th April 2024, Quiz Club NITWQuiz Club NITW
 
Active Learning Strategies (in short ALS).pdf
Active Learning Strategies (in short ALS).pdfActive Learning Strategies (in short ALS).pdf
Active Learning Strategies (in short ALS).pdfPatidar M
 
Congestive Cardiac Failure..presentation
Congestive Cardiac Failure..presentationCongestive Cardiac Failure..presentation
Congestive Cardiac Failure..presentationdeepaannamalai16
 
How to Make a Duplicate of Your Odoo 17 Database
How to Make a Duplicate of Your Odoo 17 DatabaseHow to Make a Duplicate of Your Odoo 17 Database
How to Make a Duplicate of Your Odoo 17 DatabaseCeline George
 
ICS 2208 Lecture Slide Notes for Topic 6
ICS 2208 Lecture Slide Notes for Topic 6ICS 2208 Lecture Slide Notes for Topic 6
ICS 2208 Lecture Slide Notes for Topic 6Vanessa Camilleri
 
Expanded definition: technical and operational
Expanded definition: technical and operationalExpanded definition: technical and operational
Expanded definition: technical and operationalssuser3e220a
 
CLASSIFICATION OF ANTI - CANCER DRUGS.pptx
CLASSIFICATION OF ANTI - CANCER DRUGS.pptxCLASSIFICATION OF ANTI - CANCER DRUGS.pptx
CLASSIFICATION OF ANTI - CANCER DRUGS.pptxAnupam32727
 
4.11.24 Mass Incarceration and the New Jim Crow.pptx
4.11.24 Mass Incarceration and the New Jim Crow.pptx4.11.24 Mass Incarceration and the New Jim Crow.pptx
4.11.24 Mass Incarceration and the New Jim Crow.pptxmary850239
 
Scientific Writing :Research Discourse
Scientific  Writing :Research  DiscourseScientific  Writing :Research  Discourse
Scientific Writing :Research DiscourseAnita GoswamiGiri
 
ICS2208 Lecture6 Notes for SL spaces.pdf
ICS2208 Lecture6 Notes for SL spaces.pdfICS2208 Lecture6 Notes for SL spaces.pdf
ICS2208 Lecture6 Notes for SL spaces.pdfVanessa Camilleri
 
Textual Evidence in Reading and Writing of SHS
Textual Evidence in Reading and Writing of SHSTextual Evidence in Reading and Writing of SHS
Textual Evidence in Reading and Writing of SHSMae Pangan
 
How to Fix XML SyntaxError in Odoo the 17
How to Fix XML SyntaxError in Odoo the 17How to Fix XML SyntaxError in Odoo the 17
How to Fix XML SyntaxError in Odoo the 17Celine George
 
Oppenheimer Film Discussion for Philosophy and Film
Oppenheimer Film Discussion for Philosophy and FilmOppenheimer Film Discussion for Philosophy and Film
Oppenheimer Film Discussion for Philosophy and FilmStan Meyer
 
BIOCHEMISTRY-CARBOHYDRATE METABOLISM CHAPTER 2.pptx
BIOCHEMISTRY-CARBOHYDRATE METABOLISM CHAPTER 2.pptxBIOCHEMISTRY-CARBOHYDRATE METABOLISM CHAPTER 2.pptx
BIOCHEMISTRY-CARBOHYDRATE METABOLISM CHAPTER 2.pptxSayali Powar
 
Narcotic and Non Narcotic Analgesic..pdf
Narcotic and Non Narcotic Analgesic..pdfNarcotic and Non Narcotic Analgesic..pdf
Narcotic and Non Narcotic Analgesic..pdfPrerana Jadhav
 
Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...
Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...
Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...DhatriParmar
 

Kürzlich hochgeladen (20)

Team Lead Succeed – Helping you and your team achieve high-performance teamwo...
Team Lead Succeed – Helping you and your team achieve high-performance teamwo...Team Lead Succeed – Helping you and your team achieve high-performance teamwo...
Team Lead Succeed – Helping you and your team achieve high-performance teamwo...
 
4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptx4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptx
 
Blowin' in the Wind of Caste_ Bob Dylan's Song as a Catalyst for Social Justi...
Blowin' in the Wind of Caste_ Bob Dylan's Song as a Catalyst for Social Justi...Blowin' in the Wind of Caste_ Bob Dylan's Song as a Catalyst for Social Justi...
Blowin' in the Wind of Caste_ Bob Dylan's Song as a Catalyst for Social Justi...
 
Q-Factor General Quiz-7th April 2024, Quiz Club NITW
Q-Factor General Quiz-7th April 2024, Quiz Club NITWQ-Factor General Quiz-7th April 2024, Quiz Club NITW
Q-Factor General Quiz-7th April 2024, Quiz Club NITW
 
Active Learning Strategies (in short ALS).pdf
Active Learning Strategies (in short ALS).pdfActive Learning Strategies (in short ALS).pdf
Active Learning Strategies (in short ALS).pdf
 
Congestive Cardiac Failure..presentation
Congestive Cardiac Failure..presentationCongestive Cardiac Failure..presentation
Congestive Cardiac Failure..presentation
 
How to Make a Duplicate of Your Odoo 17 Database
How to Make a Duplicate of Your Odoo 17 DatabaseHow to Make a Duplicate of Your Odoo 17 Database
How to Make a Duplicate of Your Odoo 17 Database
 
ICS 2208 Lecture Slide Notes for Topic 6
ICS 2208 Lecture Slide Notes for Topic 6ICS 2208 Lecture Slide Notes for Topic 6
ICS 2208 Lecture Slide Notes for Topic 6
 
INCLUSIVE EDUCATION PRACTICES FOR TEACHERS AND TRAINERS.pptx
INCLUSIVE EDUCATION PRACTICES FOR TEACHERS AND TRAINERS.pptxINCLUSIVE EDUCATION PRACTICES FOR TEACHERS AND TRAINERS.pptx
INCLUSIVE EDUCATION PRACTICES FOR TEACHERS AND TRAINERS.pptx
 
Expanded definition: technical and operational
Expanded definition: technical and operationalExpanded definition: technical and operational
Expanded definition: technical and operational
 
CLASSIFICATION OF ANTI - CANCER DRUGS.pptx
CLASSIFICATION OF ANTI - CANCER DRUGS.pptxCLASSIFICATION OF ANTI - CANCER DRUGS.pptx
CLASSIFICATION OF ANTI - CANCER DRUGS.pptx
 
4.11.24 Mass Incarceration and the New Jim Crow.pptx
4.11.24 Mass Incarceration and the New Jim Crow.pptx4.11.24 Mass Incarceration and the New Jim Crow.pptx
4.11.24 Mass Incarceration and the New Jim Crow.pptx
 
Scientific Writing :Research Discourse
Scientific  Writing :Research  DiscourseScientific  Writing :Research  Discourse
Scientific Writing :Research Discourse
 
ICS2208 Lecture6 Notes for SL spaces.pdf
ICS2208 Lecture6 Notes for SL spaces.pdfICS2208 Lecture6 Notes for SL spaces.pdf
ICS2208 Lecture6 Notes for SL spaces.pdf
 
Textual Evidence in Reading and Writing of SHS
Textual Evidence in Reading and Writing of SHSTextual Evidence in Reading and Writing of SHS
Textual Evidence in Reading and Writing of SHS
 
How to Fix XML SyntaxError in Odoo the 17
How to Fix XML SyntaxError in Odoo the 17How to Fix XML SyntaxError in Odoo the 17
How to Fix XML SyntaxError in Odoo the 17
 
Oppenheimer Film Discussion for Philosophy and Film
Oppenheimer Film Discussion for Philosophy and FilmOppenheimer Film Discussion for Philosophy and Film
Oppenheimer Film Discussion for Philosophy and Film
 
BIOCHEMISTRY-CARBOHYDRATE METABOLISM CHAPTER 2.pptx
BIOCHEMISTRY-CARBOHYDRATE METABOLISM CHAPTER 2.pptxBIOCHEMISTRY-CARBOHYDRATE METABOLISM CHAPTER 2.pptx
BIOCHEMISTRY-CARBOHYDRATE METABOLISM CHAPTER 2.pptx
 
Narcotic and Non Narcotic Analgesic..pdf
Narcotic and Non Narcotic Analgesic..pdfNarcotic and Non Narcotic Analgesic..pdf
Narcotic and Non Narcotic Analgesic..pdf
 
Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...
Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...
Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...
 

Health Stats Ksa

  • 1. Epidemiology of CHD risk factors in Saudi Arabia Dr. Alaa Elalem Medical Department Pfizer, Jeddah, Saudi Arabia
  • 2.  
  • 3.  
  • 4.  
  • 5.  
  • 6. Young population 79 % under age of 40 42 % under age of 20 16 %at age of 40-60 5 % over age of 60 WHR2006
  • 7. Life expectancy at birth WHR 2006 Rank Country Life expectancy at birth ( years) 1 San Marino 82 3 Japan 82 20 Germany 79 28 USA 78 38 UAE 77 61 Syria 72 80 Saudi Arabia 71 88 Turkey 71 107 Egypt 68 192 Zimbabwe 36
  • 8. Global distribution of healthcare Physicians WHR 2006 Rank Country Physician Density per 1000 1 San Marino 47.35 / 1990 26 Germany 3.37 / 2003 47 USA 2.56 / 2000 62 UAE 2.02 / 2001 64 Japan 1.98 / 2002 76 Syria 1.40 / 2001 77 Saudi Arabia 1.30 / 2004 79 Turkey 1.35 / 2003 120 Egypt 0.54 / 2003 192 Malawi 0.02 / 2004
  • 9. Global distribution of healthcare Pharmacists WHR 2006 Rank Country Pharmacist Density per 1000 1 Jordan 3.14 / 2004 5 Japan 2.21 / 2002 19 USA 0.88 / 2000 37 Germany 0.58 / 2003 45 Syria 0.52 / 2001 59 UAE 0.38 / 2001 63 Turkey 0.32 / 2003 76 Saudi Arabia 0.22 / 2004 94 Egypt 0.10 / 2004 161 Somalia (8) 0.00 / 1997 162 Cuba 0
  • 10. Global distribution of healthcare Nurses WHR 2006 Rank Country Nurses density per 1000 1 San Marino 95.48 / 1990 15 Germany 9.72 / 2003 19 U.S.A. 9.37 / 2000 27 Japan 7.79 / 2002 60 U.A.E. 4.18 / 2001 88 Saudi Arabia 2.97 / 2004 104 Egypt 2.00 / 2004 106 Syria 1.94 / 2001 111 Turkey 1.70 / 2003 190 Bangladesh 0.14 / 2004
  • 11. Healthcare expenditure indicators WHR 2006 Rank Country Per Capital Total Expenditure on Health at international dollar Rate (US$)- 2003 1 USA 5711 8 Germany 3001 21 Japan 2244 54 UAE 623 59 Saudi Arabia 578 67 Turkey 528 108 Egypt 235 137 Syria 116 191 Democratic republic of Congo 14
  • 12. Healthcare expenditure indicators WHR 2006 Rank Country Total Expenditure of Health as % of GDP -2003 1 USA 15.2 6 Germany 11.1 10 Lebanon 10.2 41 Japan 7.9 48 Turkey 7.6 97 Egypt 5.8 122 Syria 5.1 154 Saudi Arabia 4 175 UAE 3.3 191 Equatorial Guinea 1.5
  • 15. Top 10 cause of Death in K.S.A.
  • 16. Top 10 cause of Death in K.S.A. 30 %
  • 17.
  • 18.
  • 19. Prevalence of Hypertension in Saudi Arabia AL-Nozha et al in a cross-sectional cluster sampling & house hold survey on 13700 Saudis of both sexes Kingdomwide Ann Saudi Med, Vol 17, No2.1997
  • 20. Comparative Prevalence of hypertension and the expected hypertension population in each country Journal of Hypertension 2005, Vol 23 No 6
  • 21.
  • 22.
  • 23. Prevalence of DM in Saudi Arabia
  • 24. Prevalence of DM in Saudi Arabia
  • 25. Prevalence of DM in Saudi Adults Overall prevalence rate of Diabetes Mellitus was is 23.7% and IFG 14.1% based on 1997 American Diabetes Association (ADA) criteria and adopted by the World Health Organization (WHO) in 1998 Al-Nozha MM et al. Diabetes mellitus in Saudi Arabia. Saudi Med J 2004;25 (11): 1603-1610
  • 26.  
  • 27.  
  • 28. General Mortality in Saudi diabetics 2000 Saudi diabetics ( Initial )
  • 29. Prevalence of obesity in Saudi Adults
  • 30. Prevalence of obesity in Saudi Adults
  • 31. Prevalence of obesity in Saudi Adults
  • 32. Prevalence of Metabolic Syndrome in Saudi Adults Overall prevalence rate of metabolic syndrome as defined by the Adult Treatment Panel (ATP) III in 2001 was 39.3%.
  • 33. The prevalence of regular smokers in each country Journal of Hypertension 2005, Vol 23 No 6
  • 34. “A Man is as Old as His Arteries” Dr Thomas Sydenham (1624-89 )